David Moore to Mycobacterium tuberculosis
This is a "connection" page, showing publications David Moore has written about Mycobacterium tuberculosis.
Connection Strength
1,296
-
Prolonged-course tuberculosis treatment or secondary prevention for those at high risk of recurrence? Clin Microbiol Infect. 2022 05; 28(5):631-633.
Score: 0,601
-
Role of Streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed Mycobacterium tuberculosis in children: a pneumococcal conjugate vaccine probe study. Pediatr Infect Dis J. 2010 Dec; 29(12):1099-04.
Score: 0,277
-
Transmission of drug-resistant tuberculosis in HIV-endemic settings. Lancet Infect Dis. 2019 03; 19(3):e77-e88.
Score: 0,121
-
Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis. Nat Genet. 2018 02; 50(2):307-316.
Score: 0,114
-
Recombination in pe/ppe genes contributes to genetic variation in Mycobacterium tuberculosis lineages. BMC Genomics. 2016 Feb 29; 17:151.
Score: 0,100
-
Impact of the antiretroviral treatment program on the burden of hospitalization for culture-confirmed tuberculosis in South African children: a time-series analysis. Pediatr Infect Dis J. 2013 Sep; 32(9):972-7.
Score: 0,084